アフェレーシスの世界市場2021-2028

◆英語タイトル:GLOBAL APHERESIS MARKET FORECAST 2021-2028
◆商品コード:INK21JU002
◆発行会社(リサーチ会社):Inkwood Research
◆発行日:2021年5月3日
◆ページ数:242
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Multi LicenseUSD3,000 ⇒換算¥330,000見積依頼/購入/質問フォーム
Enterprisewide PriceUSD4,500 ⇒換算¥495,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はInkwood Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Inkwood Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートはアフェレーシスの世界市場について調査・分析し、調査範囲/手法、エグゼクティブサマリー、市場動向、主要分析、処置別(血漿浄化療法、血小板フェレーシス、白血球除去療法、赤血球除去療法、その他)分析、技術別(遠心分離、膜分離)分析、製品別(使い捨てアフェレーシスキット、アフェレーシス機械)分析、用途別(血液疾患、神経疾患、自己免疫疾患、腎疾患、その他)分析、地域別分析、競争状況などを掲載したものです。
・調査範囲/手法
・エグゼクティブサマリー
・市場動向
・主要分析
・アフェレーシスの世界市場規模:処置別(血漿浄化療法、血小板フェレーシス、白血球除去療法、赤血球除去療法、その他)
・アフェレーシスの世界市場規模:技術別(遠心分離、膜分離)
・アフェレーシスの世界市場規模:製品別(使い捨てアフェレーシスキット、アフェレーシス機械)
・アフェレーシスの世界市場規模:用途別(血液疾患、神経疾患、自己免疫疾患、腎疾患、その他)
・地域別分析
・競争状況
【レポートの概要】

KEY FINDINGS
The global apheresis market growth is estimated to progress at a CAGR of 8.31% during the forecast period, 2021-2028. The increasing elderly population, hematologic disease prevalence, favorable reimbursement policies and funding, and technological advancements in apheresis techniques drive market growth.
MARKET INSIGHTS
Apheresis is a medical process wherein whole blood is removed from a donor or patient. The blood is separated into individual components for removing any particular component. This is done through membrane separation or centrifugation process. Blood diseases affect the total health of the body and are caused by certain genes. Some common blood diseases are von Willebrand disease (VWD), hemophilia, anemia, and blood cancer. These diseases entail blood transfusion, which is projected to increase the need for apheresis.
Plasma exchange and cytapheresis are the two most common types of apheresis used for eliminating harmful substances from the blood. Plasma exchange is utilized for treating disorders like multiple sclerosis, thrombotic thrombocytopenic purpura, myasthenia gravis, etc. Cytapheresis is a process that eliminates the excess number of blood cells. It is used to treat polycythemia, thrombocythemia, and leukemia. The growing incidence of hematologic diseases is thus evaluated to promote market growth.
REGIONAL INSIGHTS
The global apheresis market growth assessment includes the analysis of Asia-Pacific, Europe, North America, and Rest of World. North America is set to be the dominating region in the global market. The growing number of neurology apheresis procedures and the increasing number of plasma exchange procedures are contributing to the market prospects of the region.
COMPETITIVE INSIGHTS
Some of the eminent companies in the market are Cytosorbents Corporation, Asahi Kasei Corporation, Baxter International Inc, B Braun Melsungen AG, Cerus Corporation, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

【レポートの目次】

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. PREVAILING INCIDENCE OF HEMATOLOGIC DISEASES
3.1.2. ADVANCEMENT IN TECHNOLOGIES OF APHERESIS TECHNIQUE
3.1.3. FAVORABLE REIMBURSEMENT POLICIES AND FUNDING FOR APHERESIS PROCEDURES
3.1.4. GROWING GERIATRIC POPULATION
3.2. KEY RESTRAINTS
3.2.1. RISK OF BLOOD CONTAMINATION WHILE CONDUCTING TRANSFUSIONS
3.2.2. HIGH COST OF INVESTMENT ASSOCIATED WITH APHERESIS PROCEDURES
3.2.3. LACK OF SKILLED PROFESSIONALS IN DEVELOPING AND UNDERDEVELOPED COUNTRIES
4. KEY ANALYTICS
4.1. IMPACT OF COVID-19 ON APHERESIS MARKET
4.2. KEY MARKET TRENDS
4.3. PORTER’S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. SUBSTITUTION
4.3.4. NEW ENTRY
4.3.5. INDUSTRY RIVALRY
4.4. OPPORTUNITY MATRIX
4.5. VENDOR LANDSCAPE
5. MARKET BY PROCEDURE
5.1. PLASMAPHERESIS
5.2. PLATELETPHERESIS
5.3. LEUKAPHERESIS
5.4. ERYTHROCYTAPHERESIS
5.5. OTHER APHERESIS PROCEDURES
6. MARKET BY TECHNOLOGY
6.1. CENTRIFUGATION
6.2. MEMBRANE SEPARATION
7. MARKET BY PRODUCT
7.1. DISPOSABLE APHERESIS KITS
7.2. APHERESIS MACHINE
8. MARKET BY APPLICATION
8.1. HEMATOLOGICAL DISORDERS
8.2. NEUROLOGICAL DISORDERS
8.3. AUTOIMMUNE DISORDERS
8.4. RENAL DISORDERS
8.5. OTHER APPLICATIONS
9. MARKET BY END-USER
9.1. BLOOD BANKS/ BLOOD DONATION CENTERS
9.2. HOSPITALS & CLINICS
9.3. AMBULATORY SURGICAL CENTERS
10. GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1. MARKET SIZE & ESTIMATES
10.1.2. KEY GROWTH ENABLERS
10.1.3. KEY CHALLENGES
10.1.4. KEY PLAYERS
10.1.5. COUNTRY ANALYSIS
10.1.5.1. UNITED STATES
10.1.5.2. CANADA
10.2. EUROPE
10.2.1. MARKET SIZE & ESTIMATES
10.2.2. KEY GROWTH ENABLERS
10.2.3. KEY CHALLENGES
10.2.4. KEY PLAYERS
10.2.5. COUNTRY ANALYSIS
10.2.5.1. GERMANY
10.2.5.2. FRANCE
10.2.5.3. UNITED KINGDOM
10.2.5.4. ITALY
10.2.5.5. RUSSIA
10.2.5.6. BELGIUM
10.2.5.7. POLAND
10.2.5.8. REST OF EUROPE
10.3. ASIA-PACIFIC
10.3.1. MARKET SIZE & ESTIMATES
10.3.2. KEY GROWTH ENABLERS
10.3.3. KEY CHALLENGES
10.3.4. KEY PLAYERS
10.3.5. COUNTRY ANALYSIS
10.3.5.1. CHINA
10.3.5.2. JAPAN
10.3.5.3. INDIA
10.3.5.4. AUSTRALIA & NEW ZEALAND
10.3.5.5. SOUTH KOREA
10.3.5.6. INDONESIA
10.3.5.7. THAILAND
10.3.5.8. VIETNAM
10.3.5.9. REST OF ASIA-PACIFIC
10.4. REST OF WORLD
10.4.1. MARKET SIZE & ESTIMATES
10.4.2. KEY GROWTH ENABLERS
10.4.3. KEY CHALLENGE
10.4.4. KEY PLAYERS
10.4.5. REGIONAL ANALYSIS
10.4.5.1. LATIN AMERICA
10.4.5.2. MIDDLE EAST & AFRICA
11. COMPETITIVE LANDSCAPE
11.1. KEY STRATEGIC DEVELOPMENTS
11.1.1. MERGERS & ACQUISITIONS
11.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
11.1.3. PARTNERSHIPS & AGREEMENTS
11.1.4. BUSINESS EXPANSIONS, ANNOUNCEMENTS & DIVESTITURES
11.2. COMPANY PROFILES
11.2.1. ASAHI KASEI CORPORATION
11.2.2. BAXTER INTERNATIONAL INC
11.2.3. B BRAUN MELSUNGEN AG
11.2.4. CERUS CORPORATION
11.2.5. CYTOSORBENTS CORPORATION
11.2.6. FRESENIUS SE & CO KGAA (FRESENIUS KABI AG)
11.2.7. HAEMONETICS CORPORATION
11.2.8. HEMACARE CORPORATION
11.2.9. INFOMED
11.2.10. KANEKA CORPORATION
11.2.11. KAWASUMI LABORATORIES INC
11.2.12. MEDICAP CLINIC GMBH
11.2.13. MEDICA SPA
11.2.14. MILTENYI BIOTEC
11.2.15. TERUMO CORPORATION (TERUMO BCT)

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT - APHERESIS
TABLE 2: GLOBAL APHERESIS MARKET, BY PROCEDURE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 3: GLOBAL APHERESIS MARKET, BY PROCEDURE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 4: GLOBAL PLASMAPHERESIS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 5: GLOBAL PLASMAPHERESIS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 6: GLOBAL PLATELETPHERESIS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 7: GLOBAL PLATELETPHERESIS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 8: GLOBAL LEUKAPHERESIS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 9: GLOBAL LEUKAPHERESIS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 10: GLOBAL ERYTHROCYTAPHERESIS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 11: GLOBAL ERYTHROCYTAPHERESIS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 12: GLOBAL OTHER APHERESIS PROCEDURES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 13: GLOBAL OTHER APHERESIS PROCEDURES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 14: GLOBAL APHERESIS MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 15: GLOBAL APHERESIS MARKET, BY TECHNOLOGY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 16: GLOBAL CENTRIFUGATION MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 17: GLOBAL CENTRIFUGATION MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 18: GLOBAL MEMBRANE SEPARATION MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 19: GLOBAL MEMBRANE SEPARATION MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 20: GLOBAL APHERESIS MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 21: GLOBAL APHERESIS MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 22: GLOBAL DISPOSABLE APHERESIS KITS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 23: GLOBAL DISPOSABLE APHERESIS KITS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 24: GLOBAL APHERESIS MACHINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 25: GLOBAL APHERESIS MACHINE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 26: GLOBAL APHERESIS MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 27: GLOBAL APHERESIS MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 28: GLOBAL HEMATOLOGICAL DISORDERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 29: GLOBAL HEMATOLOGICAL DISORDERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 30: GLOBAL NEUROLOGICAL DISORDERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 31: GLOBAL NEUROLOGICAL DISORDERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 32: GLOBAL AUTOIMMUNE DISORDERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 33: GLOBAL AUTOIMMUNE DISORDERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 34: GLOBAL RENAL DISORDERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 35: GLOBAL RENAL DISORDERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 36: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 37: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 38: GLOBAL APHERESIS MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 39: GLOBAL APHERESIS MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 40: GLOBAL BLOOD BANKS/ BLOOD DONATION CENTERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 41: GLOBAL BLOOD BANKS/ BLOOD DONATION CENTERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 42: GLOBAL HOSPITALS & CLINICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 43: GLOBAL HOSPITALS & CLINICS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 44: GLOBAL AMBULATORY SURGICAL CENTERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 45: GLOBAL AMBULATORY SURGICAL CENTERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 46: GLOBAL APHERESIS MARKET, BY REGION, HISTORIC YEARS, 2016-2020 (IN $ MILLION)
TABLE 47: GLOBAL APHERESIS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 48: NORTH AMERICA APHERESIS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 49: NORTH AMERICA APHERESIS MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 50: LEADING PLAYERS OPERATING IN NORTH AMERICA APHERESIS MARKET
TABLE 51: EUROPE APHERESIS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 52: EUROPE APHERESIS MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 53: LEADING PLAYERS OPERATING IN EUROPE APHERESIS MARKET
TABLE 54: ASIA-PACIFIC APHERESIS MARKET, BY COUNTRY, HISTORIC YEARS, 2016-2020 (IN $ MILLION)
TABLE 55: ASIA-PACIFIC APHERESIS MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 56: LEADING PLAYERS OPERATING IN ASIA-PACIFIC APHERESIS MARKET
TABLE 57: REST OF WORLD APHERESIS MARKET, BY REGION, HISTORIC YEARS, 2016-2020 (IN $ MILLION)
TABLE 58: REST OF WORLD APHERESIS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 59: LEADING PLAYERS OPERATING IN REST OF WORLD APHERESIS MARKET
TABLE 60: LIST OF MERGERS & ACQUISITIONS
TABLE 61: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 62: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 63: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES


LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER’S FIVE FORCES ANALYSIS
FIGURE 3: OPPORTUNITY MATRIX
FIGURE 4: VENDOR LANDSCAPE
FIGURE 5: GLOBAL APHERESIS MARKET, BY PROCEDURE, IN 2020
FIGURE 6: GLOBAL APHERESIS MARKET, BY PLASMAPHERESIS, 2021-2028 (IN $ MILLION)
FIGURE 7: GLOBAL APHERESIS MARKET, BY PLATELETPHERESIS, 2021-2028 (IN $ MILLION)
FIGURE 8: GLOBAL APHERESIS MARKET, BY LEUKAPHERESIS, 2021-2028 (IN $ MILLION)
FIGURE 9: GLOBAL APHERESIS MARKET, BY ERYTHROCYTAPHERESIS, 2021-2028 (IN $ MILLION)
FIGURE 10: GLOBAL APHERESIS MARKET, BY OTHER APHERESIS PROCEDURES, 2021-2028 (IN $ MILLION)
FIGURE 11: GLOBAL APHERESIS MARKET, BY TECHNOLOGY, IN 2020
FIGURE 12: GLOBAL APHERESIS MARKET, BY CENTRIFUGATION, 2021-2028 (IN $ MILLION)
FIGURE 13: GLOBAL APHERESIS MARKET, BY MEMBRANE SEPARATION, 2021-2028 (IN $ MILLION)
FIGURE 14: GLOBAL APHERESIS MARKET, BY PRODUCT, IN 2020
FIGURE 15: GLOBAL APHERESIS MARKET, BY DISPOSABLE APHERESIS KITS, 2021-2028 (IN $ MILLION)
FIGURE 16: GLOBAL APHERESIS MARKET, BY APHERESIS MACHINE, 2021-2028 (IN $ MILLION)
FIGURE 17: GLOBAL APHERESIS MARKET, BY APPLICATION, IN 2020
FIGURE 18: GLOBAL APHERESIS MARKET, BY HEMATOLOGICAL DISORDERS, 2021-2028 (IN $ MILLION)
FIGURE 19: PREVALENCE OF BLEEDING DISORDER GLOBALLY, IN 2019
FIGURE 20: GLOBAL APHERESIS MARKET, BY NEUROLOGICAL DISORDERS, 2021-2028 (IN $ MILLION)
FIGURE 21: GLOBAL APHERESIS MARKET, BY AUTOIMMUNE DISORDERS, 2021-2028 (IN $ MILLION)
FIGURE 22: GLOBAL APHERESIS MARKET, BY RENAL DISORDERS, 2021-2028 (IN $ MILLION)
FIGURE 23: GLOBAL APHERESIS MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 24: GLOBAL APHERESIS MARKET, BY END-USER, IN 2020
FIGURE 25: GLOBAL APHERESIS MARKET, BY BLOOD BANKS/ BLOOD DONATION CENTERS, 2021-2028 (IN $ MILLION)
FIGURE 26: GLOBAL APHERESIS MARKET, BY HOSPITALS & CLINICS, 2021-2028 (IN $ MILLION)
FIGURE 27: GLOBAL APHERESIS MARKET, BY AMBULATORY SURGICAL CENTERS, 2021-2028 (IN $ MILLION)
FIGURE 28: NORTH AMERICA APHERESIS MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
FIGURE 29: UNITED STATES APHERESIS MARKET, 2021-2028 (IN $ MILLION)
FIGURE 30: CANADA APHERESIS MARKET, 2021-2028 (IN $ MILLION)
FIGURE 31: EUROPE APHERESIS MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
FIGURE 32: GERMANY APHERESIS MARKET, 2021-2028 (IN $ MILLION)
FIGURE 33: FRANCE APHERESIS MARKET, 2021-2028 (IN $ MILLION)
FIGURE 34: UNITED KINGDOM APHERESIS MARKET, 2021-2028 (IN $ MILLION)
FIGURE 35: ITALY APHERESIS MARKET, 2021-2028 (IN $ MILLION)
FIGURE 36: RUSSIA APHERESIS MARKET, 2021-2028 (IN $ MILLION)
FIGURE 37: BELGIUM APHERESIS MARKET, 2021-2028 (IN $ MILLION)
FIGURE 38: POLAND APHERESIS MARKET, 2021-2028 (IN $ MILLION)
FIGURE 39: REST OF EUROPE APHERESIS MARKET, 2021-2028 (IN $ MILLION)
FIGURE 40: ASIA-PACIFIC APHERESIS MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
FIGURE 41: CHINA APHERESIS MARKET, 2021-2028 (IN $ MILLION)
FIGURE 42: JAPAN APHERESIS MARKET, 2021-2028 (IN $ MILLION)
FIGURE 43: INDIA APHERESIS MARKET, 2021-2028 (IN $ MILLION)
FIGURE 44: AUSTRALIA & NEW ZEALAND APHERESIS MARKET, 2021-2028 (IN $ MILLION)
FIGURE 45: SOUTH KOREA APHERESIS MARKET, 2021-2028 (IN $ MILLION)
FIGURE 46: INDONESIA APHERESIS MARKET, 2021-2028 (IN $ MILLION)
FIGURE 47: THAILAND APHERESIS MARKET, 2021-2028 (IN $ MILLION)
FIGURE 48: VIETNAM APHERESIS MARKET, 2021-2028 (IN $ MILLION)
FIGURE 49: REST OF ASIA-PACIFIC APHERESIS MARKET, 2021-2028 (IN $ MILLION)
FIGURE 50: REST OF WORLD APHERESIS MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
FIGURE 51: LATIN AMERICA APHERESIS MARKET, 2021-2028 (IN $ MILLION)
FIGURE 52: MIDDLE EAST & AFRICA APHERESIS MARKET, 2021-2028 (IN $ MILLION)


【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[アフェレーシスの世界市場2021-2028]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆